Akademik Veri Yönetim Sistemi
AÇBİD’25 18. Uluslararası Kongresi, Antalya, Türkiye, 24 - 27 Nisan 2025, ss.1-15, (Tam Metin Bildiri)
AMELOBLASTOMA: DIFFERENT TREATMENT STRATEGİES
Objective: Ameloblastoma is a rare, benign but locally aggressive odontogenic tumor that originates from the epithelial cells involved in tooth development. The surgical approach to treating an ameloblastoma depends on the type, size, location, patient’s age and overall health. A series of 4 ameloblastoma patients are presented retrospectively.
Materials-Methods: Case notes of four ameloblastoma caseswere retrospectively evaluated. The patients’ gender, age, clicical findings, CBCT datas, histopathologic results, histosurgical approaches, recurrence status, placement ofreconstruction plate (RP), follow-up duration and surgical techniques were examined descriptively.
Results: Two male and 2 female patients with an average age of 20 years, were involved. The average follow-up period is 6 months. All patients were fit and well with no drug history. Histopathologic results are: One unicystic ameloblastoma case, 2 acanthomatous ameloblastoma cases (one with BRAF V600E mutation), and 1 peripheral ameloblastoma case. Treatments were extra oral approach for segmental resection and reconstruction with free iliac graft, enucleationand curettage and/or application of cornoy’s solution andmarginal resection. Recurrence was not detected during the follow up period.
Conclusion: The treatment of ameloblastoma can vary based on clinical, histopathological, and radiographic findings. It is imperative to adapt between enucleation, curettage and resection based on the above criteria as well as the necessity for long follow up periods.
Keywords: Ameloblastoma, enucleation, marginal resection